145 related articles for article (PubMed ID: 21236314)
1. Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.
Dugger BN; Tu M; Murray ME; Dickson DW
Neurosci Lett; 2011 Mar; 491(2):122-6. PubMed ID: 21236314
[TBL] [Abstract][Full Text] [Related]
2. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
[TBL] [Abstract][Full Text] [Related]
3. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
[TBL] [Abstract][Full Text] [Related]
4. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
[TBL] [Abstract][Full Text] [Related]
5. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
6. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
[TBL] [Abstract][Full Text] [Related]
7. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
Garcia-Cordero I; Anastassiadis C; Khoja A; Morales-Rivero A; Thapa S; Vasilevskaya A; Davenport C; Sumra V; Couto B; Multani N; Taghdiri F; Anor C; Misquitta K; Vandevrede L; Heuer H; Tang-Wai D; Dickerson B; Pantelyat A; Litvan I; Boeve B; Rojas JC; Ljubenkov P; Huey E; Fox S; Kovacs GG; Boxer A; Lang A; Tartaglia MC;
Ann Neurol; 2024 Jul; 96(1):99-109. PubMed ID: 38578117
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
[TBL] [Abstract][Full Text] [Related]
10. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.
Kaalund SS; Passamonti L; Allinson KSJ; Murley AG; Robbins TW; Spillantini MG; Rowe JB
Acta Neuropathol Commun; 2020 Feb; 8(1):11. PubMed ID: 32019605
[TBL] [Abstract][Full Text] [Related]
11. Tau protein aggregation is associated with cellular senescence in the brain.
Musi N; Valentine JM; Sickora KR; Baeuerle E; Thompson CS; Shen Q; Orr ME
Aging Cell; 2018 Dec; 17(6):e12840. PubMed ID: 30126037
[TBL] [Abstract][Full Text] [Related]
12. Accurate digital quantification of tau pathology in progressive supranuclear palsy.
Pansuwan T; Quaegebeur A; Kaalund SS; Hidari E; Briggs M; Rowe JB; Rittman T
Acta Neuropathol Commun; 2023 Nov; 11(1):178. PubMed ID: 37946288
[TBL] [Abstract][Full Text] [Related]
13. Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.
Coughlin DG; Hiniker A; Peterson C; Kim Y; Arezoumandan S; Giannini L; Pizzo D; Weintraub D; Siderowf A; Litvan I; Rissman RA; Galasko D; Hansen L; Trojanowski JQ; Lee E; Grossman M; Irwin D
J Neuropathol Exp Neurol; 2022 Nov; 81(12):953-964. PubMed ID: 36269086
[TBL] [Abstract][Full Text] [Related]
14. Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation.
Santpere G; Ferrer I
Brain Pathol; 2009 Apr; 19(2):177-87. PubMed ID: 18462470
[TBL] [Abstract][Full Text] [Related]
15. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer's disease brain.
Frey B; Holzinger D; Taylor K; Ehrnhoefer DE; Striebinger A; Biesinger S; Gasparini L; O'Neill MJ; Wegner F; Barghorn S; Höglinger GU; Heym RG
Acta Neuropathol Commun; 2023 Nov; 11(1):181. PubMed ID: 37964332
[TBL] [Abstract][Full Text] [Related]
16. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
[TBL] [Abstract][Full Text] [Related]
17. Protracted course progressive supranuclear palsy.
Couto B; Martinez-Valbuena I; Lee S; Alfradique-Dunham I; Perrin RJ; Perlmutter JS; Cruchaga C; Kim A; Visanji N; Sato C; Rogaeva E; Lang AE; Kovacs GG
Eur J Neurol; 2022 Aug; 29(8):2220-2231. PubMed ID: 35384155
[TBL] [Abstract][Full Text] [Related]
18. Deep learning reveals disease-specific signatures of white matter pathology in tauopathies.
Vega AR; Chkheidze R; Jarmale V; Shang P; Foong C; Diamond MI; White CL; Rajaram S
Acta Neuropathol Commun; 2021 Oct; 9(1):170. PubMed ID: 34674762
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
Butler T; Wang X; Chiang G; Xi K; Niogi S; Glodzik L; Li Y; Razlighi QR; Zhou L; Hojjati SH; Ozsahin I; Mao X; Maloney T; Tanzi E; Rahmouni N; Tissot C; Lussier F; Shah S; Shungu D; Gupta A; De Leon M; Mozley PD; Pascoal TA; Rosa-Neto P
J Alzheimers Dis; 2024; 99(1):307-319. PubMed ID: 38669537
[TBL] [Abstract][Full Text] [Related]
20. In Vivo
Malpetti M; Kaalund SS; Tsvetanov KA; Rittman T; Briggs M; Allinson KSJ; Passamonti L; Holland N; Jones PS; Fryer TD; Hong YT; Kouli A; Bevan-Jones WR; Mak E; Savulich G; Spillantini MG; Aigbirhio FI; Williams-Gray CH; O'Brien JT; Rowe JB
J Nucl Med; 2022 Jul; 63(7):1052-1057. PubMed ID: 34795013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
